Literature DB >> 1309901

Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens.

C Sureau1, A M Moriarty, G B Thornton, R E Lanford.   

Abstract

Hepatitis delta virus (HDV) particles were produced in Huh7 human hepatoma cells by transfection with cloned hepatitis B virus (HBV) DNA and HDV cDNA. The particles were characterized by their buoyant density, the presence of encapsidated viral RNA, and their ability to infect primary cultures of chimpanzee hepatocytes. Successful infection was evidenced by the appearance of increasing amounts of intracellular HDV RNA after exposure to particles. Infection was prevented when particles were incubated with antibodies directed against synthetic peptides specific for epitopes of the pre-S1 or pre-S2 domains of the HBV envelope proteins before exposure to hepatocytes. These data demonstrate that HDV particles produced in vitro are infectious and indicate (i) that infectious particles are coated with HBV envelope proteins that contain the pre-S1 and pre-S2 regions, (ii) that epitopes of the pre-S1 and pre-S2 domains of HBV envelope proteins are exposed at the surface of HDV particles, and (iii) that antibodies directed against those epitopes have neutralizing activity against HDV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309901      PMCID: PMC240836     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen.

Authors:  M Y Kuo; M Chao; J Taylor
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

2.  Epitope mapping of the PreS1 domain of the hepatitis B virus large surface protein.

Authors:  K Kuroki; M Floreani; L T Mimms; D Ganem
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

3.  Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum.

Authors:  K Kuroki; R Russnak; D Ganem
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

4.  Reversible cleavage and ligation of hepatitis delta virus RNA.

Authors:  H N Wu; M M Lai
Journal:  Science       Date:  1989-02-03       Impact factor: 47.728

5.  Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus.

Authors:  D J Petcu; C E Aldrich; L Coates; J M Taylor; W S Mason
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

6.  A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus.

Authors:  M A Petit; S Dubanchet; F Capel
Journal:  Mol Immunol       Date:  1989-06       Impact factor: 4.407

7.  In vitro replication and expression of hepatitis B virus from chronically infected primary chimpanzee hepatocytes.

Authors:  J R Jacob; J W Eichberg; R E Lanford
Journal:  Hepatology       Date:  1989-12       Impact factor: 17.425

8.  Tissue culture system for infection with human hepatitis delta virus.

Authors:  C Sureau; J R Jacob; J W Eichberg; R E Lanford
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

9.  Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line.

Authors:  J C Wu; P J Chen; M Y Kuo; S D Lee; D S Chen; L P Ting
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  The role of envelope proteins in hepatitis B virus assembly.

Authors:  V Bruss; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more
  32 in total

1.  Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes.

Authors:  Severin Gudima; Yiping He; Anja Meier; Jinhong Chang; Rongji Chen; Michal Jarnik; Emmanuelle Nicolas; Volker Bruss; John Taylor
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus.

Authors:  Severin Gudima; Anja Meier; Roland Dunbrack; John Taylor; Volker Bruss
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.

Authors:  John Casey; Paul J Cote; Illia A Toshkov; Chung K Chu; John L Gerin; William E Hornbuckle; Bud C Tennant; Brent E Korba
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Authors:  Bruno B Bordier; Patricia L Marion; Kazuo Ohashi; Mark A Kay; Harry B Greenberg; John L Casey; Jeffrey S Glenn
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Experimental transmission of human hepatitis delta virus to the laboratory mouse.

Authors:  H J Netter; K Kajino; J M Taylor
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Caspase-mediated cleavage of beta-catenin precedes drug-induced apoptosis in resistant cancer cells.

Authors:  Subramanian Senthivinayagam; Prajna Mishra; Suresh Kanna Paramasivam; Srinivas Yallapragada; Malay Chatterjee; Lucas Wong; Ajay Rana; Basabi Rana
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

7.  Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes.

Authors:  Azeneth Barrera; Bernadette Guerra; Helen Lee; Robert E Lanford
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.

Authors:  Huan Yan; Bo Peng; Wenhui He; Guocai Zhong; Yonghe Qi; Bijie Ren; Zhenchao Gao; Zhiyi Jing; Mei Song; Guangwei Xu; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

9.  Packaging of hepatitis delta virus RNA via the RNA-binding domain of hepatitis delta antigens: different roles for the small and large delta antigens.

Authors:  H W Wang; P J Chen; C Z Lee; H L Wu; D S Chen
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

Review 10.  Virological and serological aspects of hepatitis B and the delta agent.

Authors:  G Hess
Journal:  Gut       Date:  1993       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.